These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 18331228)

  • 1. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.
    Yan SF; D'Agati V; Schmidt AM; Ramasamy R
    Curr Mol Med; 2007 Dec; 7(8):699-710. PubMed ID: 18331228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.
    Yan SF; Ramasamy R; Naka Y; Schmidt AM
    Circ Res; 2003 Dec; 93(12):1159-69. PubMed ID: 14670831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
    Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
    Yan SF; Ramasamy R; Schmidt AM
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.
    Ramasamy R; Yan SF; Schmidt AM
    Trends Cardiovasc Med; 2005 Oct; 15(7):237-43. PubMed ID: 16226677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end product receptor-mediated cellular dysfunction.
    Bierhaus A; Humpert PM; Stern DM; Arnold B; Nawroth PP
    Ann N Y Acad Sci; 2005 Jun; 1043():676-80. PubMed ID: 16037292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.
    Yamagishi S
    Exp Gerontol; 2011 Apr; 46(4):217-24. PubMed ID: 21111800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AGE/RAGE axis in diabetes-accelerated atherosclerosis.
    Jandeleit-Dahm K; Watson A; Soro-Paavonen A
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):329-34. PubMed ID: 18290873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE, vascular tone and vascular disease.
    Farmer DG; Kennedy S
    Pharmacol Ther; 2009 Nov; 124(2):185-94. PubMed ID: 19616578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAGE: a journey from the complications of diabetes to disorders of the nervous system - striking a fine balance between injury and repair.
    Rong LL; Gooch C; Szabolcs M; Herold KC; Lalla E; Hays AP; Yan SF; Yan SS; Schmidt AM
    Restor Neurol Neurosci; 2005; 23(5-6):355-65. PubMed ID: 16477098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
    Srikanth V; Maczurek A; Phan T; Steele M; Westcott B; Juskiw D; Münch G
    Neurobiol Aging; 2011 May; 32(5):763-77. PubMed ID: 19464758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
    Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
    J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs).
    Collison KS; Parhar RS; Saleh SS; Meyer BF; Kwaasi AA; Hammami MM; Schmidt AM; Stern DM; Al-Mohanna FA
    J Leukoc Biol; 2002 Mar; 71(3):433-44. PubMed ID: 11867681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
    Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
    Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation.
    Schmidt AM; Hofmann M; Taguchi A; Yan SD; Stern DM
    Semin Thromb Hemost; 2000; 26(5):485-93. PubMed ID: 11129404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAGE axis: Animal models and novel insights into the vascular complications of diabetes.
    Naka Y; Bucciarelli LG; Wendt T; Lee LK; Rong LL; Ramasamy R; Yan SF; Schmidt AM
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1342-9. PubMed ID: 15155381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts.
    Ramasamy R; Yan SF; Schmidt AM
    J Leukoc Biol; 2009 Sep; 86(3):505-12. PubMed ID: 19477910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury.
    Zhou Z; Wang K; Penn MS; Marso SP; Lauer MA; Forudi F; Zhou X; Qu W; Lu Y; Stern DM; Schmidt AM; Lincoff AM; Topol EJ
    Circulation; 2003 May; 107(17):2238-43. PubMed ID: 12719284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
    Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
    Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.